Update: Influenza Activity -- United States, September 28, 2008-April 4, 2009, and Composition of the 2009-10 Influenza Vaccine

Peebles, P.; Brammer, L.; Epperson, S.; Blanton, L.; Dhara, R.; Wallis, T.; Finelli, L.; Gubareva, L.; Bresee, J.; Klimov, A.; Cox, N.
April 2009
MMWR: Morbidity & Mortality Weekly Report;4/17/2009, Vol. 58 Issue 14, p369
The article presents a summary report of the U.S. influenza activity from September 28, 2008 to April 4, 2009 and the composition of the influenza vaccine for 2009-2010. From October 2008 to early January 2009, low levels of influenza activity was noted but increased from mid-January and peaked in mid-February 2009. The World Health Organization suggested that the 2009-10 Northern Hemisphere trivalent influenza vaccine contain the A/Brisbane/59/2007-like (H1N1), A/Brisbane/10/2007-like (H3N2), and B/Brisbane/60/2008-like (B/Victoria lineage) viruses.


Related Articles

  • 2004 Influenza Virus Recommendations Still Valid.  // Access;Nov2005, Vol. 19 Issue 9, p39 

    The article reports on the suitability of the strains of H5N1 influenza virus that the World Health Organization (WHO) selected in 2004 for use in vaccine development. WHO will continue to monitor antigenic and genetic changes in the A/H5N1 viruses that are still circulating, especially in...

  • Southern hemisphere influenza vaccines 2005.  // WHO Drug Information;2004, Vol. 18 Issue 4, p283 

    Reports on the recommendation from the World Health Organization of influenza virus vaccine composition for the forthcoming winter in the southern hemisphere. Responsibility of the national public health for the recommendations regarding the use of the vaccine.

  • WEBWISE. Price, Bob // Nursing Standard;3/29/2006, Vol. 20 Issue 29, p36 

    The article focuses on the Web site of the World Health Organization providing guidelines on the use of vaccines and antiviral during influenza pandemics and the global influenza program for pandemic preparedness. The site can be navigated easily and provides updated scientific information. The...

  • Influenza Vaccine 1980-1981.  // Annals of Internal Medicine;Sep80, Vol. 93 Issue 3, p466 

    Presents an annual revision of influenza vaccine recommendations in the U.S. as of 1980. Predominant strain of influenza virus in the U.S. during 1979 to 1980; Subtypes of influenza A on the basis of two antigens; General recommendations for vaccine use; Influenza vaccine available from 1980 to...

  • Immunization against Influenza: Comparison of Various Topical and Parenteral Regimens Containing Inactivated and/or Live Attenuated Vaccines in Healthy Adults. Keitel, Wendy A.; Cate, Thomas R.; Couch, Robert B.; Nino, Diane; Huggins, Linda L.; Six, Howard R.; Quarles, John M. // Journal of Infectious Diseases;1/15/2001, Vol. 183 Issue 2, p329 

    Provides information on a study which evaluated intranasal immunization with monovalent, live attenuated, cold-adapted recombinant or inactivated influenza virus (MIV) vaccine and intramuscular immunization with MIV. Information on influenza; Materials and methods used; Results; Conclusions.

  • Erratum to: Influenza A viruses: why focusing on M2e-based universal vaccines. Ebrahimi, Seyyed Mahmoud; Tebianian, Majid // Virus Genes;Feb2011, Vol. 42 Issue 1, p9 

    A correction to the article "Influenza A Viruses: Why Focusing on M2e-Based Universal Vaccines" that was published in the March 18, 2011 online issue is presented.

  • Advances in the development of influenza virus vaccines. Krammer, Florian; Palese, Peter // Nature Reviews Drug Discovery;Apr2015, Vol. 14 Issue 4, p294 

    A correction to the article "Advances in the development of influenza virus vaccines" which appeared in a 2015 issue is presented.

  • Vaccine Shortage Leaves Millions Vulnerable. Houlton, Sarah // Pharmaceutical Executive;Apr2005, Vol. 25 Issue 4, p22 

    Reports on the warning issued by the World Health Organization about the problem caused by an influenza pandemic worldwide. Number of people killed by avian influenza in Southeast Asia; Fear of experts if the virus mutates into a strain that can be passed between humans; Problem of most...

  • The end for flu viruses: one vaccine to thwart them all. MacKenzie, Debora // New Scientist;8/22/2009, Vol. 203 Issue 2722, p28 

    The article reports on the possibility of having a universal vaccine against all flu viruses and its potential of putting an end to seasonal epidemics and eventually, pandemics. The main focus of current research is the M2 protein which informs viruses that they are already inside a cell. On the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics